|
Clinical trials are the most expensive part of drug development, with candidates’ recruitments being the major time consumer of the process.
Identifying subjects requires the clinical research administrator (CRA) to act on “guesstimates” figures supplied by their health institution partner investigators, who from their end, have to go through a very cumbersome process to review the patients clinical information.
Health institutions and clinics have enormous knowledge stored within their patient records. Yet, while willing to share this information for increased research partnership and for financial gains, there are many steep hurdles to overcome:
- IT resources are scarce and expensive
- Most of the data is in free-textual documents filed in paper records
- HIPAA regulations restricts data access internally, especially when sharing information with external partners
The AccelFind™ Solution:
- Unmatchable time savings in running feasibility studies, sites selection, recruiting and subjects enrollment
- A sponsored investigator's collaborative case-finding infrastructure
- HIPAA and IRB compliant
- Service Oriented Architecture
- Rapid implementation process
|